Stay updated on Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.

Latest updates to the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This update is administrative and does not affect study details or user interactions.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision metadata updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision history updated: added revision v3.4.1 and removed v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded a 'Show glossary' option and new metadata labels ('Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', 'Revision: v3.4.0'); removed the older labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').SummaryDifference0.2%

Stay in the know with updates to Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.